CHRS FY 2019 Earnings — Coherus Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CHRSCoherus Oncology, Inc.

$219M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$356M+22783.7% YoY

Gross Profit

$339M95.2% margin

Operating Income

$108M30.3% margin

Net Income

$90M25.2% margin

EPS (Diluted)

$1.23

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$15M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$409M

Total Liabilities

$304M

Stockholders' Equity

$105M

Cash & Equivalents

$178M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$356M	$2M	+22783.7%
Gross Profit	$339M	-$2M	+20290.2%
Operating Income	$108M	-$204M	+152.7%
Net Income	$90M	-$209M	+142.9%